Jackie Fenemore qualified as a RGN in 1995 and has worked at The Christie Hospital, Manchester for over 25 years. Previously worked as lung cancer nurse specialist from 2007-2017. After completing an MSc in Advanced Practice in 2017, now continues to work in the lung cancer team as a Lung Cancer Nurse Clinician. Jackie qualified as a non- medical prescriber in 2009, and is a member of the committee for Lung Cancer Nursing U.K. (LCNUK), currently serving as the Chair. Also Jackie is on the Global Lung Cancer Coalition (GLCC) steering group. Interests include in non-operable stage 3 management of Lung Cancer with concurrent chemo-radiotherapy, as well as targeted therapies and combination treatment for stage 4 lung cancers.

Dr. Sabari is an Assistant Professor of Medicine, Thoracic Medical Oncologist and member of the Phase I Experimental Therapeutics Group in the Department of Medical Oncology at New York University School of Medicine, NYU Langone Health Perlmutter Cancer Center. Dr. Sabari’s research focus includes targeted therapy drug development in non-small cell and small cell lung cancer.